Wockhardt's US subsidiary, Wockhardt USA, has launched Ondansetron injection in the United States on December 26.
The Indian Pharmaceutical Alliance has approached regulator for a dialogue to understand the concern raised by it
The vaccine arrives at a critical moment for the US. Hospitalisations due to COVID-19 hit record highs for the seventh day in a row on Saturday.
In 2014, Sun Pharma agreed to buy Ranbaxy -- which was then controlled by Daiichi.
The dry-run was being conducted in state capitals in at least three session sites. Some states also included districts that are situated in difficult terrain or have poor logistical support, according to officials.
The FDA issued the letter on October 15, and has given the company 15 days to respond.
In order to bring uniformity, the need for following the existing framework for either imposition of restrictions or allowing relaxations based on the burden of disease and strain on healthcare infrastructure still remain important.
Sun Pharma open to large acquisitions post Ranbaxy.
Though the government has been pushing for exports of high-value manufactured goods across major markets in place of raw materials and input goods, India's top exports to China remain in the raw materials category.
There are a number of vaccine candidates already in clinical trial and a few out of those candidates have completed phase 1/2 status, he said, adding that there are trials that will be going into phase three sometime at the end of July and then others will follow in the months of August, September and October.
Having twice betrayed the BJP -- and Arvind Kejriwal determined not to admit in AAP anyone who could question his authority -- Sidhu seems to have reached a dead-end in his political career, asserts Virendra Kapoor.
The first drug to treat low sexual desire in premenopausal women, dubbed "female Viagra", has been approved in the United States, but with a warning about potentially dangerous side effects such as severe low blood pressure and fainting.
'We can't rule out the fact that the virus might have changed in such a way that it's actually causing more harm to young people.'
Fresh guidelines issued by the Union home ministry on Wednesday permit industries operating in rural areas to run from April 30 with strict social distancing norms.
Sun Pharma to retain these in most markets; US could be the exception, where the Ranbaxy name has taken a hit.
More than 30 vaccine candidates have been supported and they are in different stages of development. Three candidates are in advanced stage of Phase I, II and III trials, and more than four are in advanced pre-clinical development stage, Choubey said.
The recall is the latest in a series of problems to hit Ranbaxy, which has had all its India factories stopped from sending drugs and ingredients to the United States.
'Even if Serum Institute and Bharat Biotech were successful in ramping up production overnight, what happens to the capacity after the demand from India is met?' asks Sanjeev Nayyar.
Some Indian generic drugmakers are, however, uncertain about the pace of approvals in the near future.
The JD(U)-BJP alliance also lambasted the actress for lodging a 'baseless' first information report against the sisters of the deceased actor and questioned the 'support' extended to her by the Uddhav Thackeray government in Maharashtra, for 'reasons the Shiv Sena knows better'.
'Have discreet, separate corona and non-corona hospitals for treating these two categories of patients.' 'Concentrate on your non-corona patients as well.' 'Because then your diabetics, your hypertensives, the ones on dialysis, the asthmatics, who, if and when they get corona, are the ones who are going to require more intensive care and are going to be more at risk of death.'
'This pandemic has given him a new platform to perform,' says a member of the government. 'He should feel lucky that he has got an opportunity now to demonstrate to the world his original talent.' 'He needs a visionary script to perform.' Sheela Bhatt reports on the politics of the pandemic.
According to an official statement, the FDA has determined that the Moderna COVID-19 vaccine has met the statutory criteria for issuance of an emergency use authorisation (EUA).
Chairing the 19th meeting of the Group of Ministers (GoM) on COVID-19 through video-conference on Friday, Vardhan said India has achieved the milestone of more than 10 lakh recoveries, a recovery rate to 64.54 per cent.
Jamaica's twice 200 metres Olympic champion Veronica Campbell-Brown has escaped with a public warning by the Jamaica Athletics Administration Association for her use of a banned substance.
The Board of Control for Cricket India's Committee of Administrators will meet in Mumbai on November 3 to chalk out a plan to deal with mounting pressure from the National Anti-Doping Agency (NADA), which wants Indian cricketers under its ambit.
Wockhardt MD Murtaza Khorakiwala said his firm had responded to the FDA's observations but declined to give details.
As the Indian Army reported its first case of the infection with a 34-year-old soldier testing positive in Leh, the Army said it has taken a series of precautionary measures to prevent the spread of coronavirus among the forces such as checking flu symptoms among soldiers on their return from leave and cancelling non-essential travel, conferences and recruitment drives.
The lawsuit accuses Trump of "an unconstitutional and unlawful scheme".
Delhi Chief Minister Arvind Kejriwal will meet his six-member cabinet at 1pm on Monday as the new Aam Aadmi Party gets down to work.
Jamaica's twice Olympic 200 metres champion Veronica Campbell-Brown was suspended by her national federation on Tuesday following a positive test for a banned diuretic at a meeting last month.
The new test it will enable rapid testing amongst more people easily.
Lupin will fund the buy through $100 mn cash reserves and a bridge loan.
In a surprise announcement in April, Sun and Ranbaxy -- at that time owned by Japan's Daiichi -- declared an all-stock deal to create India's largest and world's fifth-largest drugmaker in an over $4 billion deal.
Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months
Responding to another question, Choubey said that the phase-I of clinical trials have revealed excellent safety of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd, and now their immunogenicity testing is in progress. Their phase II clinical trials are ongoing.
Cambridge, Massachusetts-based Moderna's announcement comes just a week after Pfizer and Biontech said their COVID-19 vaccine candidate was found to be more than 90 per cent effective in preventing COVID-19 in participants.
In March, he had said that China is responsible for the spread of the novel coronavirus and called the COVID-19 as the "Chinese Virus".
Think beyond engineering and medicine.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances